Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-2024-08-06· OpenAIAi2 WildChat-4.8M (AI2)

You act as a paraphrase tool. Your role involves understanding the provided text…

  1. User

    System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :

    User: From time to time, we may become involved in legal proceedings arising in the ordinary course of business. We are not currently a party to any material legal proceedings. Debt | 2027 Notes On March 9, 2020, BridgeBio issued an aggregate principal amount of BridgeBioreceivednetproceedsfromthe2020NoteOfferingofapproximatelyBridgeBio received net proceeds from the 2020 Note Offering of approximately A holder of 2027 Notes may convert all or any portion of its 2027 Notes at its option at any time prior to the close of business on the business day immediately preceding December 15, 2026 in multiples of DuringanycalendarquartercommencingafterthecalendarquarterendingonJune30,2020(andonlyduringsuchcalendarquarter),ifthelastreportedsalepriceofBridgeBio’scommonstockforatleast∣Duringthefivebusinessdayperiodafteranyfiveconsecutivetradingdayperiod(the“measurementperiod”)inwhichthe“tradingprice”(asdefinedintheIndenture)perDuring any calendar quarter commencing after the calendar quarter ending on June 30, 2020 (and only during such calendar quarter), if the last reported sale price of BridgeBio’s common stock for at least | During the five business day period after any five consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per | Upon the occurrence of specified corporate events. | On or after December 15, 2026 until the close of business on the second scheduled trading day immediately preceding the maturity date, a holder may convert all or any portion of its 2027 Notes at any time, regardless of the foregoing. Assistant:

  2. Assistant

    Positive: Occasionally, we might become engaged in legal cases that arise in the regular course of business. Currently, we are not involved in any significant legal cases. Debt | 2027 Notes On March 9, 2020, BridgeBio issued a principal amount of BridgeBiogainednetproceedsfromthe2020NoteOfferingofaboutBridgeBio gained net proceeds from the 2020 Note Offering of about A holder of 2027 Notes is allowed to convert any or all parts of its 2027 Notes at their discretion at any time before the end of business on the business day just before December 15, 2026, in multiples of DuringanycalendarquarterstartingafterthequarterendingonJune30,2020(andonlyduringthatquarter),ifthelastreportedsalepriceofBridgeBio’scommonstockforatleast∣Duringthefive−business−dayperiodafteranysequenceoffive−trading−daysperiod(the“measurementperiod”)wherethe“tradingprice”(asdescribedintheIndenture)perDuring any calendar quarter starting after the quarter ending on June 30, 2020 (and only during that quarter), if the last reported sale price of BridgeBio’s common stock for at least | During the five-business-day period after any sequence of five-trading-days period (the “measurement period”) where the “trading price” (as described in the Indenture) per | Upon the advent of certain corporate incidents. | From December 15, 2026, until the close of business on the second trading day prior to the maturity date, a holder may convert part or all of its 2027 Notes at any time, without regard to the above-mentioned stipulations.

    Negative: There is no chance we will be involved in legal proceedings stemming from usual business operations. At present, we are engaged in significant legal actions. Debt | 2027 Notes Did not issue any principal amount on March 9, 2020 | A holder of 2027 Notes cannot convert any part of its 2027 Notes at its discretion at any time before the close of business on the day prior to December 15, 2026. During any calendar quarter after the quarter ending on June 30, 2020, if the last sale price of BridgeBio’s common stock for at least | This is never allowed under any circumstances | On or after December 15, 2026 until the close of business on the second trading day immediately preceding the maturity date, a holder may not convert any portion of its 2027 Notes at any time.